Roche Holding AG Update on Sequencing Technology Presentation Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Daniel Brennan - TD Cowen - Analyst : Can you hear me okay?

Question: Daniel Brennan - TD Cowen - Analyst : I was wondering if you could start -- I know there's nothing on price yet, but you talk about this reusable kind of flow cell, I guess. Is there any way to put it in context like the most of the players will quote price per genome or price per (inaudible). Is there any way to think about it if you're not going to give numbers yet? Any way to think about like -- relatively speaking, in the zip code below above just given the profile that you have? It was the first question. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. FEBRUARY 20, 2025 / 7:30PM, ROG.S - Roche Holding AG Update on Sequencing Technology Presentation And then the second question was just back on accuracy. So the simplest accuracy is what Q20, is that right? And I know you showed Duplex at Q39 but I was just wondering if you can expand upon that a little bit, given it was unclear. I know like 50% of the reads match on Duplex, 50% don't. So I just wanted to understand, is that Q3, like you run Duplex mode, and that's what you're going to get Q39 or is there some ratio that you're calculating? Matt Sause - Roche Holding AG - Member of the Corporate Executive Committee, Chief Executive Officer of Roche Diagnostics Josh, do you want to take the first one, and I could take the second one if you want.